Sleep, testosterone and cortisol balance, and ageing men.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic, observational, and interventional studies
PubMed 36152143 · doi:10.1007/s11154-022-09755-4
What was done
This narrative review synthesized epidemiological, experimental, and interventional evidence evaluating the effects of sleep duration, sleep debt, circadian misalignment, and obstructive sleep apnea on testosterone and cortisol balance in men, as well as downstream metabolic consequences such as insulin resistance.
What was found
The abstract reports qualitative directional findings without numerical values, confidence intervals, or effect sizes. Disordered sleep and reduced sleep duration were associated with decreased morning, afternoon, and 24-hour testosterone, alongside increased afternoon cortisol (with no change in morning or 24-hour cortisol). Obstructive sleep apnea was associated with lower testosterone independently of age and obesity. Experimentally restoring testosterone and cortisol balance using a dual-hormone clamp mitigated sleep restriction-induced insulin resistance. High-dose testosterone therapy was reported to induce obstructive sleep apnea, whereas physiological dosing demonstrated potentially transient or neutral effects.
Why it matters
The review outlines how chronic sleep impairment shifts hormonal balance toward catabolism and demonstrates proof-of-concept that metabolic deficits from sleep loss can be pharmacologically targeted via endocrine pathways without increasing sleep time.
Limits
The abstract provides no quantitative metrics, meta-analytic pooling, or systematic search criteria. The underlying evidence base includes underpowered continuous positive airway pressure trials, heterogeneous observational studies prone to confounding, and early-stage experimental clamp models requiring broader validation.
Cited by
- supports Men who sleep 4 to 5 hours a night typically have testosterone levels equivalent to someone 10 years older.